Teriflunomide
Brand name: Aubagio
Rank #127 of 500 drugs by total cost
$131.9M
Total Cost
18,010
Total Claims
$131.9M
Total Cost
757
Prescribers
$7,326
Cost per Claim
588
Beneficiaries
19,677
30-Day Fills
$174K
Avg Cost/Provider
24
Avg Claims/Provider
About Teriflunomide
Teriflunomide (sold as Aubagio) was prescribed 18,010 times by 757 Medicare Part D providers in 2023, costing the program $131.9M. At $7,326 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 124 | Oxycodone Hcl/Acetaminophen (Oxycodone-Acetaminophen) | $136.4M | 3,487,099 |
| 125 | Buprenorphine Hcl/Naloxone Hcl (Buprenorphine-Naloxone) | $135.8M | 696,008 |
| 126 | Cenegermin-Bkbj (Oxervate) | $133.5M | 3,601 |
| 127 | Teriflunomide (Aubagio) | $131.9M | 18,010 |
| 128 | Umeclidinium Bromide (Incruse Ellipta) | $131.6M | 290,677 |
| 129 | Tiotropium Br/Olodaterol Hcl (Stiolto Respimat) | $130.3M | 201,233 |
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology